Panbela Therapeutics, Inc. (PBLA) Misses Q2 EPS by $1.25

Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q2 EPS of ($1.51), $1.25 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• C.H. Robinson acquires DeSpir Logistics for $75 million